WooGeneB&G

우진비앤지(주) · KOSDAQ · 018620 · Industry: Manufacture of animal medicaments

Key metrics

Earnings

Revenue, Q3 2026₩12.7bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ-18.1% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY-4.1% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026-₩144m As of Sep 30, 2026 Source 1 ↗
Operating income QoQTurned to loss As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoY+81.3% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩0 As of Nov 19, 2026
Buyback decided, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩6.0bn As of Nov 17, 2026 Source 1
Rights offering new shares, last 12 months2,200,000 shares As of Nov 17, 2026 Source 1
Potential new shares, last 12 months4,394,586 shares As of Nov 17, 2026 Source 1, Source 2
Potential new shares, % of shares63.4% As of Nov 17, 2026 Source 1, Source 2, Source 3 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩0 As of Nov 19, 2026
Supply contracts vs prior-year revenue0.0% As of Nov 19, 2026
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months10 As of Nov 19, 2026
DART filings, previous 3 months17 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)352,309 shares As of Sep 28, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more
Open-market buys, last 12 months (amount)₩1.0bn As of Sep 28, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)352,309 shares As of Sep 28, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more
Insiders who bought, last 12 months2 As of Sep 28, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more

Insider transactions (last 12 months)

Open-market buys: 352,309 shares (₩1.0bn). Open-market sells: 0 shares (₩0). Net open-market buying: +352,309 shares. Insiders who bought: 2.

Trade dateInsider (role)TypeSharesPriceAmount
Sep 28, 2026Kang Jae-gu (Registered director, Controlling shareholder)Open-market buy+35,358 shares₩2,867₩101m
Aug 20, 2026Kang Jae-gu (Registered director, Controlling shareholder)Open-market buy+34,660 shares₩2,837₩98m
Jul 31, 2026Kang Jae-gu (Registered director, Controlling shareholder)Open-market buy+68,780 shares₩2,821₩194m
Jul 15, 2026Kang Jae-gu (Registered director, Controlling shareholder)Open-market buy+3,436 shares₩2,972₩10m
Jul 14, 2026Kang Jae-gu (Registered director, Controlling shareholder)Open-market buy+73,000 shares₩2,895₩211m
Jul 13, 2026Kang Jae-gu (Registered director, Controlling shareholder)Open-market buy+51,000 shares₩2,692₩137m
Jul 10, 2026Kang Jae-gu (Registered director, Controlling shareholder)Open-market buy+19,000 shares₩2,444₩46m
Jun 15, 2026Kang Jae-gu (Registered director, Controlling shareholder)Other (Bonus shares)+179,515 shares——
Jun 15, 2026Lim Jae-chun (Non-registered officer)Other (Bonus shares)+652 shares——
Jun 10, 2026Kang Jae-gu (Registered director, Controlling shareholder)Open-market buy+9,000 shares₩3,257₩29m
Jun 10, 2026Kang Seok-jin (Registered director)Open-market buy+2,449 shares₩3,083₩8m
Jun 9, 2026Kang Jae-gu (Registered director, Controlling shareholder)Open-market buy+3,000 shares₩3,182₩10m
Jun 9, 2026Kang Seok-jin (Registered director)Open-market buy+1,000 shares₩3,110₩3m
Jun 8, 2026Kang Jae-gu (Registered director, Controlling shareholder)Open-market buy+3,000 shares₩3,088₩9m
Jun 8, 2026Kang Seok-jin (Registered director)Open-market buy+4,000 shares₩3,151₩13m
Jun 5, 2026Kang Jae-gu (Registered director, Controlling shareholder)Open-market buy+5,951 shares₩3,039₩18m
Jun 5, 2026Kang Seok-jin (Registered director)Open-market buy+5,675 shares₩3,036₩17m
Jun 4, 2026Kang Jae-gu (Registered director, Controlling shareholder)Open-market buy+30,000 shares₩3,037₩91m
Jun 4, 2026Kang Seok-jin (Registered director)Open-market buy+3,000 shares₩3,123₩9m
Apr 30, 2026Kang Jae-gu (Registered director, Controlling shareholder)Other (Reverse split)-3,386,515 shares——
Apr 30, 2026Kang Seok-jin (Registered director)Other (Reverse split)-1,629,984 shares——
Apr 30, 2026Lim Jae-chun (Non-registered officer)Other (Reverse split)-13,040 shares——

Annual financials

YearRevenueOperating income
2025₩54.8bn₩319m
2024₩55.7bn₩295m
2023₩57.9bn₩714m

Filing timeline